Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Thalidomide evaluated for toxic epidermal necrolysis and found detrimental

Dec. 10, 1998

Abgenix initiates a phase I/II clinical trial in patients with psoriasis

Dec. 3, 1998

Diane-35 now available in Canada for treatment of acne

Dec. 2, 1998

SA-9499 identified as potent and selective LTA4 hydrolase inhibitor at Santen

Nov. 27, 1998

Zileuton trials recommended for new indication: atopic dermatitis

Nov. 27, 1998

Continued positive results with fexofenadine in patients with CIU

Nov. 27, 1998

Organogenesis completes patient enrollment in Apligraf diabetic foot ulcer trial

Nov. 19, 1998

Positive phase III clinical trial results received for Olux

Nov. 12, 1998

Team from Angiotech demonstrates paclitaxel's potential as an antipsoriatic

Nov. 12, 1998

Idec Pharmaceuticals: Q3 1998 highlights

Nov. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...